Assessing Bivalent Vaccines against Covid-19

NEJM Interviews
28/09/2022 16 min

Listen "Assessing Bivalent Vaccines against Covid-19"

Descargar episodio Ver en sitio original

Episode Synopsis


Eric Rubin is the Editor-in-Chief of the Journal. Lindsey Baden is a Deputy Editor of the Journal. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. E.J. Rubin, L.R. Baden, and S. Morrissey. Audio Interview: Assessing Bivalent Vaccines against Covid-19. N Engl J Med 2022;387:e37.

More episodes of the podcast NEJM Interviews

NEJM Interview: Rachel Sachs on recent agreements governing coverage and pricing of GLP-1 receptor agonists in the United States. 07/01/2026
NEJM Interview: Ambar La Forgia on the drivers and effects of corporatization of outpatient medical services. 31/12/2025
NEJM Interview: Anne Zink on increases in rates of congenital syphilis and potential strategies for reversing this trend. 17/12/2025
NEJM Interview: Reshma Ramachandran on changes to the FDA’s adverse-event data releases and future directions for enhancing its safety-surveillance infrastructure. 10/12/2025
NEJM Interview: Robert Huckman on the dearth of successful business models aimed at keeping people healthy. 03/12/2025
NEJM Interview: Nishant Uppal on the emergence of venture capital investing by academic medical centers and its potential implications. 26/11/2025
NEJM Interview: Jane Zhu on a new Oregon law that aims to address corporate control in medicine. 19/11/2025
NEJM Interview: Joshua Barocas on recent federal actions related to harm-reduction programs for people with substance use disorders. 12/11/2025
NEJM Interview: Yashaswini Singh on antitrust enforcement as a potential counterbalance to consolidation resulting from rapid health care corporatization. 05/11/2025
NEJM Interview: Eberechi Nwogu-Onyemkpa on integrating palliative care services and resources into the management of sickle cell disease. 22/10/2025
© 2003-2026 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA